Literature DB >> 11342372

Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus.

J Rodriguez1, J E Romaguera, R L Katz, J Said, F Cabanillas.   

Abstract

Primary effusion lymphoma (PEL) is a newly described high-grade B cell lymphoma which develops in association with Kaposi's sarcoma-associated herpesvirus (KSV) in human immunodeficiency virus (HIV)-infected individuals. We hereby describe a very unusual presentation of PEL that developed in the abdominal cavity of an HIV negative, KSV negative patient with a 1-year history of refractory ascites due to alcohol-related liver cirrhosis. Possible factors aiding lymphomagenesis in the cirrhotic state are discussed.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11342372     DOI： 10.3109/10428190109057969

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


  9 in total

Review 1.  Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics.

Authors:  Savanah D Gisriel; Ji Yuan; Ryan C Braunberger; Danielle L V Maracaja; Xueyan Chen; Xiaojun Wu; Jenna McCracken; Mingyi Chen; Yi Xie; Laura E Brown; Peng Li; Yi Zhou; Tarsheen Sethi; Austin McHenry; Ronald G Hauser; Nathan Paulson; Haiming Tang; Eric D Hsi; Endi Wang; Qian-Yun Zhang; Ken H Young; Mina L Xu; Zenggang Pan
Journal:  Mod Pathol       Date:  2022-05-13       Impact factor: 8.209

2.  Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis.

Authors:  Daisuke Kaji; Yasunori Ota; Yasuharu Sato; Koji Nagafuji; Yasunori Ueda; Masataka Okamoto; Yasushi Terasaki; Naoko Tsuyama; Kosei Matsue; Tomohiro Kinoshita; Go Yamamoto; Shuichi Taniguchi; Shigeru Chiba; Koichi Ohshima; Koji Izutsu
Journal:  Blood Adv       Date:  2020-09-22

Review 3.  KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states.

Authors:  Serge Alexanian; Jonathan Said; Mark Lones; Sheeja T Pullarkat
Journal:  Am J Surg Pathol       Date:  2013-02       Impact factor: 6.394

Review 4.  Durable remission by sobuzoxane in an HIV-seronegative patient with human herpesvirus 8-negative primary effusion lymphoma.

Authors:  Yoriko Inoue; Kunihiro Tsukasaki; Kazuhiro Nagai; Hisashi Soda; Masao Tomonaga
Journal:  Int J Hematol       Date:  2004-04       Impact factor: 2.490

5.  Body Cavity-Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma.

Authors:  Junghoon Shin; Young Hyeh Ko; Sung Yong Oh; Dok Hyun Yoon; Jeong-Ok Lee; Jin Seok Kim; Yong Park; Ho Jin Shin; Seok Jin Kim; Jong Ho Won; Sung-Soo Yoon; Won Seog Kim; Youngil Koh
Journal:  Cancer Res Treat       Date:  2019-02-14       Impact factor: 4.679

6.  Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis.

Authors:  Justin J Kuhlman; Muhamad Alhaj Moustafa; Alexander J Tun; David M Menke; Han W Tun; Liuyan Jiang
Journal:  Clin Case Rep       Date:  2021-04-04

7.  HHV8-Negative Primary Effusion Lymphoma of B-Cell Lineage: Two Cases and a Comprehensive Review of the Literature.

Authors:  Neeraj Saini; Ephraim P Hochberg; Erica A Linden; Smita Jha; Heinz K Grohs; Aliyah R Sohani
Journal:  Case Rep Oncol Med       Date:  2013-01-16

8.  T Cell Primary Effusion Lymphoma in an HIV-Negative Man with Liver Cirrhosis.

Authors:  Jacqueline Kropf; Mina Gerges; Ariel Perez Perez; Austin Ellis; Mevin Mathew; Kwabena Ayesu; Li Ge; Steve J Carlan
Journal:  Am J Case Rep       Date:  2020-01-20

Review 9.  Primary Effusion Lymphoma: A Timely Review on the Association with HIV, HHV8, and EBV.

Authors:  Chih-Yi Liu; Bo-Jung Chen; Shih-Sung Chuang
Journal:  Diagnostics (Basel)       Date:  2022-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.